| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |